Status:
COMPLETED
Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Acute Coronary Syndrome
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Many people who have recently left the hospital have difficulties managing their medications, and medication errors are common. Patients with low health literacy levels may have a particularly difficu...
Detailed Description
After hospital discharge, many people experience difficulty in managing their medication regimens. This can be due to medication dosing changes, challenges in adjusting new medications with those that...
Eligibility Criteria
Inclusion
- Admitted to a participating study hospital
- Diagnosis of acute coronary syndromes or heart failure
Exclusion
- Too ill to participate
- Corrected visual acuity worse than 20/200
- Severe hearing impairment
- Patient is not being discharged to their home
- No regular telephone number
- Not fluent in English or Spanish
- Unintelligible speech
- In police custody
- Caregiver manages all medications
- Delirium or severe dementia
- Psychotic illness
- Already participating in a conflicting study
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
862 Patients enrolled
Trial Details
Trial ID
NCT00632021
Start Date
May 1 2008
End Date
March 1 2012
Last Update
September 1 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
2
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232